These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3049234)

  • 1. [The genetics of breast cancer, population and familial research and segregation analysis].
    Nefedov MD; Gar'kavtseva RF; Trubnikov VI
    Genetika; 1988 Jun; 24(6):1105-12. PubMed ID: 3049234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinico-genetical analysis of colonic cancer. I. Occurrence, frequency in families and segregation analysis].
    Belev NF; Gar'kavtseva RF; Samotyia EE; Trubnikov VI; Gindilis VM
    Genetika; 1986 Sep; 22(9):2347-54. PubMed ID: 3770477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Genetic study of psoriasis in the Kharkov population].
    Atramentova LA; Ryzhko PP; Fedota AM
    Tsitol Genet; 2001; 35(1):74-8. PubMed ID: 11589049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The genetics of breast cancer. A genetic dispersion analysis and the genetic heterogeneity of breast cancer].
    Nefedov MD; Gar'kavtseva RF; Trubnikov VI
    Genetika; 1988 Aug; 24(8):1456-61. PubMed ID: 3203886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of risk factor covariates in a segregation analysis of a population-based sample of 426 breast cancer families.
    Grabrick DM; Anderson VE; King RA; Kushi LH; Sellers TA
    Genet Epidemiol; 1999; 16(2):150-64. PubMed ID: 10030398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segregation analysis of breast cancer in a population-based sample of postmenopausal probands: The Iowa Women's Health Study.
    Chen PL; Sellers TA; Rich SS; Potter JD; Folsom AR
    Genet Epidemiol; 1995; 12(4):401-15. PubMed ID: 8536957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic epidemiology of breast cancer: segregation analysis of 389 Icelandic pedigrees.
    Baffoe-Bonnie AB; Beaty TH; Bailey-Wilson JE; Kiemeney LA; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2000 Jan; 18(1):81-94. PubMed ID: 10603460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
    J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Segregation analysis of 231 Ashkenazi Jewish families for evidence of additional breast cancer susceptibility genes.
    Kaufman DJ; Beaty TH; Struewing JP
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1045-52. PubMed ID: 14578141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Familial-populational studies of endometrial cancer: segregation and genetic dispersion analyses].
    Boĭko IuV; Ganina KP; Kolesnik IaF; Nesina IP; Nefedov MD; Polishchuk LZ
    Vopr Onkol; 1992; 38(11):1293-9. PubMed ID: 1343157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
    Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
    Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic epidemiology study of ovarian cancer. I. A comparison of familial and population frequencies].
    Chudina AP; Akulenko LV
    Genetika; 1984 May; 20(5):849-56. PubMed ID: 6539727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inherited predisposition to breast cancer: after the BRCA1 and BRCA2 genes, what next?].
    Bonadona V; Lasset C
    Bull Cancer; 2003 Jul; 90(7):587-94. PubMed ID: 12957799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Segregation and genetic dispersion analysis of the pedigrees of breast cancer patients in the Kiev region].
    Naleskina LA; Ganina KP; Osinskaia EV; Borodaĭ NV
    Tsitol Genet; 1995; 29(5):60-4. PubMed ID: 8721848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the MYH gene do not substantially contribute to the risk of breast cancer.
    Beiner ME; Zhang WW; Zhang S; Gallinger S; Sun P; Narod SA
    Breast Cancer Res Treat; 2009 Apr; 114(3):575-8. PubMed ID: 18454351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ; Garber J; Kiousis S; Calzone K; Hauser ER; Merajver SD; Frank TS; Boehnke M; Chamberlain JS; Collins FS
    J Natl Cancer Inst Monogr; 1995; (17):9-14. PubMed ID: 8573462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk models for familial ovarian and breast cancer.
    Antoniou AC; Gayther SA; Stratton JF; Ponder BA; Easton DF
    Genet Epidemiol; 2000 Feb; 18(2):173-90. PubMed ID: 10642429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer risk of heterozygotes with the NBN founder mutation.
    Seemanová E; Jarolim P; Seeman P; Varon R; Digweed M; Swift M; Sperling K
    J Natl Cancer Inst; 2007 Dec; 99(24):1875-80. PubMed ID: 18073374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
    Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
    Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.